Skip to main content
. 2021 Dec 6;24(3):264–276. doi: 10.1111/codi.15997

TABLE 1.

Patient population

Patient characteristics No AL AL 95% CI Total P
Age Median (IQR) 67.0 (58.8–74.8) 67.4 (58.3–74.1) 67.1 (58.7–74.7) 0.624
Sex Female 1966 (92.3) 164 (7.7) 6.6–8.9 2130 (100) <0.001
Male 2879 (88.1) 388 (11.9) 10.8–13 3267 (100)
(Missing) 1 (100.0) 0 (0.0) 1 (100)
BMI Median (IQR) 25.2 (22.9–27.8) 25.6 (23.3–28.4) 25.3 (23.0–27.8) 0.054
CCI 2 2103 (90.6) 218 (9.4) n.a. 2321 (100) 0.602
3 867 (89.8) 99 (10.2) 10.8–13 966 (100)
4–5 515 (89.4) 61 (10.6) 8.4–12.3 576 (100)
6+ 140 (88.1) 19 (11.9) 8.2–13.4 159 (100)
(Missing) 1221 (88.7) 155 (11.3) 1376 (100)
ASA score I 564 (91.0) 56 (9.0) 9.6–13.1 620 (100) 0.279
II 1950 (89.0) 242 (11.0) 6.9–11.6 2192 (100)
III 1068 (88.0) 146 (12.0) 9.8–12.4 1214 (100)
IV 55 (90.2) 6 (9.8) 10.3–14 61 (100)
(Missing) 1209 (92.2) 102 (7.8) 1311 (100)
Weight loss a No 2789 (91.0) 276 (9.0) 6.4–9.4 3065 (100) 0.045
Yes 277 (87.4) 40 (12.6) 8–10.1 317 (100)
(Missing) 1780 (88.3) 236 (11.7) 2016 (100)
Smoking habits No 2395 (90.5) 250 (9.5) 10.3–13.2 2645 (100) 0.290
Yes 903 (89.3) 108 (10.7) 8.4–10.6 1011 (100)
(Missing) 1548 (88.9) 194 (11.1) 1742 (100)
Alcohol habits No 3008 (90.3) 324 (9.7) 9.7–12.7 3332 (100) 0.724
Yes 254 (89.4) 30 (10.6) 8.7–10.8 284 (100)
(Missing) 1584 (88.9) 198 (11.1) 1782 (100)
Perioperative treatment No 1216 (90.7) 124 (9.3) 1340 (100) 0.851
Short‐course RT 113 (92.6) 9 (7.4) n.a. 122 (100)
Long‐course RT 146 (91.2) 14 (8.8) n.a. 160 (100)
Short‐course RT + CT 189 (89.2) 23 (10.8) 7.8–10.9 212 (100)
Long‐course RT + CT 1394 (89.9) 156 (10.1) 3.4–13.5 1550 (100)
CT 377 (91.1) 37 (8.9) 4.9–14.3 414 (100)
(Missing) 1411 (88.2) 189 (11.8) 1600 (100)
Neoadjuvant treatment No 1216 (90.7) 124 (9.3) 8.6–11.7 1340 (100) 0.680
Yes 2219 (90.3) 239 (9.7) 6.4–12.1 2458 (100)
(Missing) 1411 (88.2) 189 (11.8) 1600 (100)

Bold indicated significance value (P < 0.05).

Abbreviations: AL, anastomotic leak; ASA, American Society of Anesthesiologists; BMI, body mass index; CCI, Charlson Comorbidity Index; CT, chemotherapy; IQR, interquartile range; RT, radiation therapy.

a

Weight loss: reduction of more than 10% of body weight within the last 6 months.